Description: Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of medicine primarily in China. The company operates through Chemical and Biological Medicine, and Health Industry segments. It offers drugs for cardiac and premature ventricular beats, sinus bradycardia, chronic heart failure, integrated rhythm regulation, cold and respiratory, cardiovascular and cerebrovascular diseases, diabetes field, tumor medication, and others. The company sells its products through physical display and online. Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded in 1992 and is based in Shijiazhuang, China.
Home Page: www.yiling.cn
No. 238 Tianshan Street
Shijiazhuang,
050035
China
Phone:
86 311 8590 1311
Officers
| Name | Title |
|---|---|
| Mr. Xiang Jun Wu | GM & Director |
| Mr. Chen Guang Li | CFO & Director |
| Ms. Wei Wang | Deputy GM & Director of Admin. Department |
| Mr. Wei Dong Xu | Director of HR & Director |
| Ms. Rui Wu | Sec. of the Board & Non-Independent Director |
| Mr. Shao Hua Zhao | Deputy Gen. Mang. |
| Ms. Yue Zhi Han | Production Management Committee Director & Deputy GM |
| Ms. Qiu Lian Zhang | Deputy GM & Non-Independent Director |
Exchange: SHE
Country: CN
Currency: Renminbi (¥)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 32.1522 |
| Price-to-Book MRQ: | 8.5138 |
| Price-to-Sales TTM: | 7.5871 |
| IPO Date: | 2011-07-28 |
| Fiscal Year End: | December |
| Full Time Employees: | 15155 |